Intelligence Profile
Research Papers
Research Papers and Clinical Trials
Recent research on platelet-rich plasma (PRP) spans multiple medical specialties, with studies examining its effectiveness across various conditions. However, the evidence base shows mixed study designs and limited large-scale trials.
Musculoskeletal Applications
Several studies have investigated PRP for orthopedic conditions. A retrospective study examined ultrasound-guided PRP injections for chronic low back pain, while a prospective randomized controlled trial compared PRP versus steroid injections for lateral epicondylitis (tennis elbow). Another completed clinical trial (NCT05248061) compared PRP combined with exercise versus exercise alone for subacromial impingement syndrome. A Phase 2 trial (NCT04315103) evaluated combining PRP with hyaluronic acid versus PRP alone for knee osteoarthritis.
The evidence also includes research on PRP's role in total knee arthroplasty (NCT01563380), suggesting interest in its use during surgical procedures.
Reproductive Medicine
A meta-analysis of randomized controlled trials examined intrauterine PRP infusion for patients with recurrent implantation failure in assisted reproduction. This represents higher-quality evidence given its systematic approach to combining multiple RCTs, though the specific number of included studies and participants is not detailed in the available information.
Other Applications
Research has explored PRP in diverse areas including:
- Hair loss treatment, with a retrospective study examining PRP combined with systemic therapies for androgenetic alopecia
- Orthodontics, through a split-mouth controlled study evaluating PRP's effect on tooth movement rate
- Ophthalmology, with a completed trial (NCT06323902) testing PRP for macular holes
- Dermatology applications, including cultured skin graft formation and oral submucous fibrosis treatment
Study Quality Limitations
Many of the recent studies are retrospective in design, which limits the strength of evidence compared to prospective randomized trials. Sample sizes are not specified in the available abstracts, making it difficult to assess the statistical power of individual studies.
Emerging Research
Current recruiting trials include a Phase 1/2 study (NCT06661382) examining cord blood-derived PRP versus placebo for vulvar lichen sclerosus, representing an innovative approach to PRP sourcing.
Note: This synthesis is based on limited abstract information. Full study details, including sample sizes, specific outcomes, and effect sizes, would require review of complete publications. Consult healthcare providers for treatment decisions.